early onset (VEO) polycystic kidney disease (PKD) in a large international pediatric cohort
referred for clinical indications over a 10-year period (2010–2020). Methods All samples
were tested by Sanger sequencing and multiplex ligation-dependent probe amplification
(MLPA) of PKD1 and PKD2 genes and/or a next-generation sequencing panel of 15
additional cystic genes including PKHD1 and HNF1B. Two patients underwent exome or …